|
|
|
|
Norfloxacin
|
| |
|
| |
Norfloxacin, sold in English speaking countries under the following brand names, Apo-Norflox, Chibroxin, Floxin, Insensye, Norflohexal, Noroxin; Nufloxib, Roxin, Utin and Utinor, is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections. It is also sometimes used to treat stomach infections.
roquinolones are generally well tolerated with most side effects being mild and serious adverse effects being rarely.

Discussion
Ask a question about 'Norfloxacin'
Start a new discussion about 'Norfloxacin'
Answer questions from other users
|
Encyclopedia
Norfloxacin, sold in English speaking countries under the following brand names, Apo-Norflox, Chibroxin, Floxin, Insensye, Norflohexal, Noroxin; Nufloxib, Roxin, Utin and Utinor, is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections. It is also sometimes used to treat stomach infections.
Adverse effects
Fluoroquinolones are generally well tolerated with most side effects being mild and serious adverse effects being rarely. Some of the serious adverse effects which occur more commonly with fluoroquinolones than with other antibiotic drug classes include CNS and tendon toxicity. The currently marketed quinolones have safety profiles similar to that of other antimicrobial classes.
The serious events may occur with therapeutic or with acute overdose. At therapeutic doses they include: central nervous system toxicity, cardiovascular toxicity, tendon / articular toxicity, and rarely hepatic toxicity. Events that may occur in acute overdose are rare and include: renal failure and seizure. Children and the elderly are at greater risk. Adverse reactions may manifest during, as well as after fluoroquinolone therapy. Acute pancreatitis has been reported as a rare but serious adverse reaction of norfloxacin.
Some groups refer to these adverse events as "fluoroquinolone toxicity". These groups of people claim to have suffered serious long term harm to their health from using fluoroquinolones. This has led to a class action lawsuit by people harmed by the use of fluoroquinolones as well as action by the consumer advocate group Public Citizen. Partly as a result of the efforts of Public Citizen the FDA ordered a black box warnings on all fluoroquinolones advising consumers of the possible toxic effects of fluoroquinolones on tendons.
Mechanism of action
The mechanism of action of norfloxacin involves inhibition of the A subunit of bacterial DNA gyrase, an enzyme which is essential for DNA replication.
|
| |
|
|